BioTechCube Luxembourg
Integrated Diagnostics Secures $10M for Clinical Feasibility Studies for Lung Cancer, AD Biomarkers
Premium
The company next year plans to launch a 1,000-patient verification trial for its lung cancer protein biomarker panel, with trials for its Alzheimer's disease panel likely to follow, said an official.